207 related articles for article (PubMed ID: 15955412)
1. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.
Plenge P; Wiborg O
Neurosci Lett; 2005 Aug; 383(3):203-8. PubMed ID: 15955412
[TBL] [Abstract][Full Text] [Related]
2. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
Chen F; Larsen MB; Sánchez C; Wiborg O
Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
4. Binding of S-citalopram and paroxetine discriminates between species.
Elfving B; Wiborg O
Synapse; 2005 Mar; 55(4):280-2. PubMed ID: 15668984
[No Abstract] [Full Text] [Related]
5. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter.
Larsen MA; Plenge P; Andersen J; Eildal JN; Kristensen AS; Bøgesø KP; Gether U; Strømgaard K; Bang-Andersen B; Loland CJ
Br J Pharmacol; 2016 Mar; 173(5):925-36. PubMed ID: 26699847
[TBL] [Abstract][Full Text] [Related]
7. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
Plenge P; Gether U; Rasmussen SG
Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
9. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
Mortensen OV; Kristensen AS; Wiborg O
J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
Sur C; Betz H; Schloss P
J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an allosteric citalopram-binding site at the serotonin transporter.
Chen F; Larsen MB; Neubauer HA; Sánchez C; Plenge P; Wiborg O
J Neurochem; 2005 Jan; 92(1):21-8. PubMed ID: 15606893
[TBL] [Abstract][Full Text] [Related]
12. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
13. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
[TBL] [Abstract][Full Text] [Related]
14. The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. A species-scanning mutagenesis study.
Larsen MB; Elfving B; Wiborg O
J Biol Chem; 2004 Oct; 279(40):42147-56. PubMed ID: 15271993
[TBL] [Abstract][Full Text] [Related]
15. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
Barker EL; Perlman MA; Adkins EM; Houlihan WJ; Pristupa ZB; Niznik HB; Blakely RD
J Biol Chem; 1998 Jul; 273(31):19459-68. PubMed ID: 9677366
[TBL] [Abstract][Full Text] [Related]
16. DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer.
Hummerich R; Reischl G; Ehrlichmann W; Machulla HJ; Heinz A; Schloss P
J Neurochem; 2004 Sep; 90(5):1218-26. PubMed ID: 15312176
[TBL] [Abstract][Full Text] [Related]
17. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
[TBL] [Abstract][Full Text] [Related]
18. The serotonin transporter from human brain: purification and partial characterization.
Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.
Plenge P; Abramyan AM; Sørensen G; Mørk A; Weikop P; Gether U; Bang-Andersen B; Shi L; Loland CJ
Nat Commun; 2020 Mar; 11(1):1491. PubMed ID: 32198394
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
Agnel M; Esnaud H; Langer SZ; Graham D
Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
